Web-ASCO Key Takeaways
Key Takeaways from ASCO Annual Meeting 2022 Cromos Pharma’s CEO Vlad Bogin recently attended the ASCO Annual Meeting (Jun 3-7). Read his key takeaways from the event. It was a great pleasure to participate in this year’s ASCO meeting, the first in-person event since the onset of the COVID-19 pandemic. While my primary interest is in getting to know the companies that
Cromos Pharma Names New Head of Feasibility and Therapeutic Strategy Bulgun Margaeva
Cromos Pharma Names New Head of Feasibility and Therapeutic Strategy Cromos Pharma is delighted to welcome Bulgun Margaeva to our team. Bulgun takes up the role of Head of Feasibility and Therapeutic Strategy.  Skilled Clinical Research Professional Bulgun is a well-recognized specialist with over 15 years of experience in pharmaceutical industry including work at AstraZeneca, Amgen, Novartis and Roche. She gradually ascended to leadership positions, where she
Cromos Pharma Names New Country Head in Poland, bozeba sasorska
Cromos Pharma Names New Country Head in Poland Cromos Pharma is happy to introduce Bozena “Bona” Sasorska as the new Country Head in Poland.  Bona as a clinical research professional has a comprehensive and demonstrated understanding of the entire drug development process. With over 25 five years of clinical development Project Management, Operations and Monitoring experience in the United States and Europe working with the largest Global

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us